Microparticles as vaccine adjuvants and delivery systems (Q35192199)

7 August 2017

1 reference

title

Microparticles as vaccine adjuvants and delivery systems (English)

1 reference

7 August 2017

1 reference

Derek T O'Hagan

1

1 reference

7 August 2017

Manmohan Singh

series ordinal

2

1 reference

7 August 2017

publication date

1 April 2003

1 reference

Expert Review of Vaccines

7 August 2017

published in

1 reference

7 August 2017

volume

2

1 reference

7 August 2017

issue

2

1 reference

7 August 2017

page(s)

269-283

1 reference

Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

Rational approaches to reduce adverse reactions in man to vaccines containing tetanus and diphtheria toxoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

In vivo distribution of radioactivity in mice after injection of biodegradable polymer microspheres containing 14C-labeled tetanus toxoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

Detoxification of endotoxin by aluminum hydroxide adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

The instructive role of innate immunity in the acquired immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

CpG motifs in bacterial DNA trigger direct B-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

A Toll-like receptor recognizes bacterial DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

Immunological adjuvants: a role for liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

Immunogenicity and protectivity of a new liposomal hepatitis A vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

ISCOMs and other saponin based adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

Biodegradable microspheres in drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

Analysis of poly(D,L-lactic-co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

Development of a preventive vaccine for Ebola virus infection in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

The preparation, characterization, and evaluation of cationic microparticles for DNA vaccine delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

Cationic microparticles are an effective delivery system for immune stimulatory cpG DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

Ambiguities in the preclinical quality assessment of microparticulate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

On technological and immunological benefits of multivalent single-injection microsphere vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody responses similar or superior to those obtained with aluminum hydroxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

A single-step immunization by sustained antigen release

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

Towards clinical testing of a single-administration tetanus vaccine based on PLA/PLGA microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

Poly[di(carboxylatophenoxy)phosphazene] (PCPP) is a potent immunoadjuvant for an influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

Synthesis and assembly of hepatitis B virus surface antigen particles in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

A protein particle vaccine containing multiple malaria epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

Optimism over vaccines administered via mucosal surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

Microparticles for intranasal immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

Oral immunization with an anti-idiotypic antibody to the exoglycolipid antigen protects against experimental Chlamydia trachomatis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

Protection against vaginal SIV transmission with microencapsulated vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

Biologically erodable microspheres as potential oral drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

Enteral immunization and challenge of volunteers given enterotoxigenic E. coli CFA/II encapsulated in biodegradable microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

Catching target receptors for drug and vaccine delivery using TOGA gene expression profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.2.2.269

21 January 2018

Identifiers

DOI

10.1586/14760584.2.2.269

1 reference

7 August 2017

1 reference